SurgePays Inc (SURG)
NASDAQCommunication ServicesSoftware - ApplicationSnapshot 2026-09-04
$0.17+0.67%
Close 2026-09-04 · 1-day change
NASDAQCommunication ServicesSoftware - ApplicationSnapshot 2026-09-04
Intact: The reason to own it still holds.
SurgePays aims to grow revenue through prepaid services, targeting $16M+ in 2026. The company cut losses from $12.8M to $11.2M in early 2026. A new AI deal could boost revenue per subscriber. Debt financing supports near-term liquidity.
Revenue declined from $16.19M to $15.98M in Q1 2026, missing forecasts. Operating losses remain large and persistent. The stock is down over 50% from highs amid legal and regulatory risks.
The market prices in about 18% revenue growth but expects ongoing losses and weak profitability. Our fair value at $3.68 reflects these challenges and the high risk profile.
Breaks if: Failure to meet Nasdaq listing requirements leads to delisting
Breaks if: Liquidity shortfall or inability to service debt
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround opportunity with a medium confidence level. The current thesis state is cautious, as the company has been experiencing volatility and is loss-making.
The market appears to have priced in a low valuation compared to peers, suggesting that expectations are not overly optimistic. However, there is a notable expectations gap indicating that the market anticipates continued challenges.
Fundamentals may struggle in the near term due to a high probability of an earnings miss, as the company has a history of disappointing results. Management's focus on subscriber growth and cost discipline shows some promise, but execution has been mixed.
The long-term thesis hinges on the performance of sector bellwethers and SURG's ability to execute on its growth strategies. Any cuts to guidance or negative earnings reports from competitors could significantly impact sentiment.
The most important moves since the prior daily snapshot.
risk label changed from 'elevated' to 'high'.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Operating losses worsen or remain above $10M through FY26
Breaks if: Revenue falls below $16M in FY26
In the next 1 to 3 years, SURG's outlook remains uncertain, driven by high risk and mixed execution. Not investment advice.